The cellular landscape of druggable RNA-binding proteins.

Cell surface RNA-binding proteins are emerging as potential biomarkers and immunotherapy targets, with specificities linked to cell type and disease, including cancer.

• Why it matters: Understanding RBPs is vital because they regulate all aspects of RNA metabolism and influence cell identity and disease progression, yet their surface localization and therapeutic potential remain underexplored.
• What they did: The study reviews intracellular functions of RBPs, their disease associations, especially in cancer, and discusses strategies to exploit their cell surface presence for developing new immunotherapies.
• The result: This work highlights the promise of targeting cell surface RBPs for diagnostics and treatments, paving the way for innovative approaches in disease management and personalized medicine.